Results 241 to 250 of about 2,442,163 (295)

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Exploring Public Interest in Multiple Sclerosis and Its Treatment Measures in the United States: A Google Trends Analysis. [PDF]

open access: yesCureus
Siddiqui ZS   +7 more
europepmc   +1 more source

Public interest in drug-related problems reflected in information search trends: an infodemiological study. [PDF]

open access: yesDaru
Martínez-Aguilar L   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy